NCT06940700View on ClinicalTrials.gov

Clinical Study on the Efficacy and Safety of SHR-4597 Inhalant in Adult Patients With Asthma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions
Asthma
Interventions
DRUG

SHR4597

SHR4597

DRUG

Budesonide inhalant

Budesonide inhalant

Trial Locations (1)

Unknown

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Guangdong Hengrui Pharmaceutical Co., Ltd

INDUSTRY